Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
23.39
-0.10 (-0.45%)
Feb 9, 2026, 3:04 PM EST - Market open
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.42 billion as of February 9, 2026. Its market cap has increased by 59.15% in one year.
Market Cap
3.42B
Enterprise Value
3.30B
1-Year Change
59.15%
Ranking
Category
Stock Price
$23.39
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.42B, an increase of 95.37%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.43B | -6.08% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 3.80B |
| Ligand Pharmaceuticals | 3.75B |
| Liquidia | 3.74B |
| Arcutis Biotherapeutics | 3.35B |
| Denali Therapeutics | 3.29B |
| Alumis | 3.26B |
| Viking Therapeutics | 3.21B |
| Xenon Pharmaceuticals | 3.20B |